
Sign up to save your podcasts
Or
We love to hear from our listeners. Send us a message.
TC BioPharm's CEO Bryan Kobel explains gamma delta t cells (GDT) in depth as well as the advantages of using GDT cells as a cell therapy vehicle. He discusses why the publicly-traded, clinical-stage cell therapy company conducts and manages all clinical trials in house as well as the unique challenges and benefits that come along with doing so.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
TC BioPharm's CEO Bryan Kobel explains gamma delta t cells (GDT) in depth as well as the advantages of using GDT cells as a cell therapy vehicle. He discusses why the publicly-traded, clinical-stage cell therapy company conducts and manages all clinical trials in house as well as the unique challenges and benefits that come along with doing so.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
760 Listeners
1,871 Listeners
30,675 Listeners
3,191 Listeners
32,105 Listeners
2,671 Listeners
268 Listeners
317 Listeners
30 Listeners
2,119 Listeners
144 Listeners
18 Listeners
15 Listeners
52 Listeners
162 Listeners